Etanercept biosimilar (AXXO)

依那西普生物类似药 (AXXO)

Report date: 2025/07/31 13:30:09

Base Information

Drug NameEtanercept biosimilar (AXXO)
Drug Alias Name依那西普生物仿制药 (AXXO)Etanercept follow-on biologicTNF-a-Fc
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionTumor necrosis factor α inhibitorsTumor necrosis factor β inhibitors
TargetsTumor necrosis factor αTumor necrosis factor β
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsArthritis, Rheumatoid
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2013/01/01
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAxxo
China Registration ClassN/A

Develop Information

Active CompaniesAxxo
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeL04AB01
Related LinksN/A